Gregory M Weinhoff is Chief Business Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 171,524 shares of CNTA, which is worth approximately $2.8 Million. The most recent transaction as insider was on Sep 30, 2022, when has been sold 11,282 shares (Ordinary Shares) at a price of $4.25 per share, resulting in proceeds of $47,948. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 172K
12.04% 3M change
33.28% 12M change
Total Value Held $2.8 Million

Gregory M Weinhoff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2022
SELL
Payment of exercise price or tax liability
$47,948 $4.25 p/Share
11,282 Reduced 4.7%
228,718 Ordinary Shares
Sep 30 2022
SELL
Open market or private sale
$16,280 $4.07 p/Share
4,000 Reduced 1.67%
236,000 Ordinary Shares
Jul 01 2022
BUY
Grant, award, or other acquisition
-
230,000 Added 48.94%
240,000 Ordinary Shares
Jun 02 2021
BUY
Open market or private purchase
$200,000 $20.0 p/Share
10,000 Added 50.0%
10,000 Ordinary Shares
GMW

Gregory M Weinhoff

Chief Business Officer
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA